Skip to main content
SpringerLink
Log in

Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper

  • Biomarkers for Alzheimer’s Disease Trials — Biomarkers for What? A Discussion Paper
  • Published:
JNHA - The Journal of Nutrition, Health and Aging

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Alzheimers Assoc, Natl Inst Aging. Consensus report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease”. Neurobiol Aging 1998; 19: 109–116.

    Article  Google Scholar 

  2. Foy CM, Nicholas H, Hollingworth P et al. Diagnosing Alzheimer’s disease — nonclinicians and computerised algorithms together are as accurate as the best clinical practice. Int J Geriatr Psychiatry 2007; 22: 1154–1163.

    Article  PubMed  Google Scholar 

  3. Dubois B, Feldman HH, Jacova C et al. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007; 6(8):734–746.

    Article  PubMed  Google Scholar 

  4. Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Neurology. 2007;69(24):2197–2204. Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

    Article  PubMed  Google Scholar 

  5. Holmes C, Boche D, Wilkinson D et al. Lancet. 2008; 372(9634):216–223. Long-term effects of Abeta 42 immunisation in Alzheimer’s disease: follow-up of a randomised, placebo-controlled phase I trial

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. NIHR Biomedical Research Centre for Mental Health, King’s College London, Institute of Psychiatry, De Crespigny Park, London, SE5 8AF, UK

    S. Lovestone

  2. Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bldg. 9, Rm. 1S126 MSC 0947, Bethesda, Maryland, 20892-0947, USA

    M. Thambisetty

Authors
  1. S. Lovestone
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Thambisetty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Lovestone.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lovestone, S., Thambisetty, M. Biomarkers for Alzheimer’s disease trials — biomarkers for what? A discussion paper. J Nutr Health Aging 13, 334–336 (2009). https://doi.org/10.1007/s12603-009-0033-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-009-0033-x

Keywords

Search

Navigation